Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Capital/Financing Update 2015

Oct 12, 2015

65124_rns_2015-10-12_71b2a547-9403-4cac-b948-7d07ade71da5.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

Imugene Limited ACN 009 179 551 Suite 1, 1233 High Street Armadale VIC 3142

13 October 2015

==> picture [175 x 57] intentionally omitted <==

Imugene announces bonus options issue

The Board of Imugene Limited (ASX: IMU) ( Imugene ) confirms that it intends to issue bonus loyalty options to all eligible shareholders in Australia and New Zealand, as originally announced in Imugene’s ASX announcement dated Tuesday, 8 September 2015, of a successful capital raising, through $3m in placement commitments to sophisticated investors.

It is currently intended that all eligible shareholders in Australia and New Zealand on the company register of shareholders as at 7.00pm (Sydney time) on Friday, 30 October 2015 will be granted, for nil consideration, 2 options for every 15 shares in the company. New shares issued under the aforementioned placement, are ineligible to participate in this bonus options issue. The option will be to subscribe for an ordinary share in the company at 1.5 cents per share, on the same terms as the options to be issued to participants in the placement. All options are intended to be listed on the Australian Securities Exchange.

A prospectus for the options will be sent to eligible shareholders. The indicative timetable is as follows:

Lodgment of prospectus Friday, 23 October 2015
Shares trade ex-bonus option
entitlements and deferred settlement Wednesday, 28 October 2015
trading commences
Record date for bonus options Friday, 30 October 2015
Issue date of bonus options anddeferred settlement trading ends Monday, 9 November 2015
Despatch date of holding statements forbonus Options Tuesday, 10 November 2015
Expiry date 31 March 2017

Investors looking for further information should refer to the Company’s website (www.imugene.com).

For enquiries contact:

Paul Hopper Justyn Stedwell/Phillip Hains
Executive Chairman Joint Company Secretaries
Imugene Limited Imugene Limited
Telephone: +61 2 9007 5585 Telephone:+61 3 9824 5254
Facsimile: +61 3 9822 7735 Facsimile:+61 3 9822 7735
Website: http://www.imugene.com Website:http://www.imugene.com

IMUGENE LIMITED Telephone +61 3 9824 5254 Fax +61 3 9822 7735 Website www.imugene.com